Clinical Trial

Michigan Initial Experience Using Tigertriever for Thrombectomy

Study acronym: MIGHTY
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this research study is to collect data about the effectiveness (i.e. how the device works) and safety (how safe it is to use such a device) of the Tigertriever in restoring blood flow by removing thrombus (or blood clot) from a large intracranial vessel (blood vessel in the brain) in patients experiencing ischemic stroke within 8 hours of symptom onset.
Protocol Amendment History 1 change
critical Recruitment opened 2026-05-09
Trial Details
NCT Number NCT07363525
Lead Sponsor Henry Ford Health System
Conditions Blood Clot, Thrombectomy, Ischemic Stroke
Enrollment 150 participants
Start Date 2026-01-15
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-08